Nutex Health Q1 revenue rises 2.2% but misses estimates

Nutex Health

30/04/2026 21:11

Overview

US healthcare operator's Q1 revenue rose 2.2% but missed analyst expectations

Net income attributable to Nutex Health more than doubled year-over-year

Revenue growth driven by higher acuity claims and favorable dispute resolution outcomes

Outlook

Company plans to open three new hospitals later in 2026

Nutex Health targets sustainable pace of three to five hospital openings annually

Company to begin selective self-development of new facilities through real estate division in 2026

Result Drivers

IDR OUTCOMES - Co said favorable outcomes in the Independent Dispute Resolution process supported hospital revenue

STOCK-BASED COMPENSATION DECLINE - Net stock-based compensation expense fell sharply year-over-year

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
Miss
$216.49 mln
$227.89 mln (3 Analysts)
Q1 Net Income
$62.76 mln
Q1 EBIT
$81.27 mln
Q1 Gross Profit
$91.73 mln
Q1 Pretax Profit
$76.56 mln


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

Wall Street's median 12-month price target for Nutex Health Inc is $215.00, about 91.9% above its April 29 closing price of $112.02

The stock recently traded at 6 times the next 12-month earnings vs. a P/E of 8 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)